1. Homepage
  2. Equities
  3. Poland
  4. Warsaw Stock Exchange
  5. Mabion S.A.
  6. Company
    MAB   PLMBION00016


Delayed Warsaw Stock Exchange  -  05/17 11:55:43 am EDT
27.98 PLN   +1.75%
04/21Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
2021Mabion S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
2021MABION S.A.(WSE : MAB) added to S&P Global BMI Index
Business Summary
Mabion SA is a Poland-based company engaged in the research and development of biotechnological and biopharmaceutical medicinal products. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in biotechnology field, including BioCentrum Ltd and Biotech Consulting Ltd. The Company specializes in the humanized monoclonal antibodies (mAbs) technology, a new generation of biotechnological drugs. It focuses on oncology drugs used to treat blood cancer, lymphomas and leukemias, rheumatoid arthrisis, as well as breast cancer. It operates its own Research and Development Center in the Special Economical Zone in Lodz, Poland.
Name Title Age Since
Krzysztof Kaczmarczyk President-Management Board & CEO - 2021
Grzegorz Mariusz Grabowicz Finance Director 48 2019
Slawomir Jaros, Dr. Chief Operating & Scientific Officer - -
Adam Pietruszkiewicz Member-Management Board - 2021
Katarzyna Kutera-Wasiak Chief Accountant - -
Members of the board
Name Title Age Since
Robert Leszek Konski Independent Member-Supervisory Board 56 2017
David John James Independent Member-Supervisory Board - -
Slawomir Kosciak Member-Supervisory Board 37 2021
Zofia Szewczuk Independent Member-Supervisory Board - -
Jˇzef Antoni Banach Deputy Chairman-Supervisory Board 48 -
Wojciech Wosko Member-Supervisory Board - 2021
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 16,161,326 10,295,378 63.7% 0 0.0% 63.7%
Twiti Investment Ltd. 2,674,617 16.5%
Investors TFI SA 1,502,649 9.30%
Polfarmex SA 1,474,346 9.12%
Maciej Wieczorek 1,097,135 6.79%
Generali PTE SA 888,456 5.50%
Nationale-Nederlanden PTE SA 875,555 5.42%
Celon Pharma S.A. 620,350 3.84%
Deka Investment GmbH 276,912 1.71%
MetLife PTE SA 94,504 0.58%
SSgA Funds Management, Inc. 21,993 0.14%
Company contact information
Mabion SA
ul. gen. Mariana Langiewicza 60
Konstantynˇw Lˇdzki, Lodz 95-050

Phone : +
Fax : +48.42.355.1777
Web : http://www.mabion.eu
Brand Portfolio
In partnership withAllbrands.markets
More brands of Mabion S.A.